Effects of Wobenzym® Plus in Healthy, Sportive People After Eccentric Exercise

Exclusion Criteria

• •Relevant history or presence of any medical disorder, potentially interfering with this trial (e.g. volunteers having experienced any cardiovascular events such as infarction, angina, surgical endocoronary intervention, stroke or volunteers suffering from diabetes as well as acute or chronic injury of the musculoskeletal system, e.g. cruciate ligament rupture.
• •No intake of anti-inflammatory medication/ food supplements or intake of medications that directly affect parameters of muscle function or performance within 4 weeks prior to visit 1 or during the trial
• •Subjects not willing to abstain from intake of analgesic medication 24 hours prior to and during visit 1 and 2.
• •For this trial clinically relevant abnormal laboratory, vital signs or physical findings at screening
• •Known hypersensitivity to the study preparation or to single ingredients (e.g. Lactose intolerance)
• •Drug, alcohol and/or medication abuse
• •Known HIV-infection
• •Known acute or chronic hepatitis B and C infection
• •Participation in another clinical trial within the last 4 weeks and concurrent participation in another clinical trial
• •Blood donation within 4 weeks prior to trial start (visit 1) or during trial.